Thiotropium bromide in the treatment of chronic obstructive pulmonary disease

Full Text

About the authors

E I Shmelev

References

  1. Barnes P. J. Muscarinic receptor subtypes in airways. Life Sci. 1993; 52: 521-527.
  2. Barnes P. J. Bronchodilators: basic pharmacology. In: Carver ley P., Pride N., edrs. Chronic obstructive pulmonary disease. London: Chapman & Hall; 1995. 391-417.
  3. Disse В., Reichl R., Speck G. et al. Ba679BR, a novel long-acting anticholinergic bronchodilator. Life Sci. 1993; 52: 537- 544.
  4. Tadjkarimi S., Yacouls M. N. et al. Effect of Ba679BR, a novel longacting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways. Am. J. Respir. Crit. Care Med. 1994; 150: 1640-1645.
  5. Maesen F. P. V., Smeets J. J., Costongs M. A. L. et al. Ba679BK, a new long acting antimuscarinic bronchodilator: a pilot close escalation study in COPD. Eur. Respir. J. 1993; 6: 1031-1036.
  6. Maesen F. P. V., Smeets J. J., Sledsens T. J. H. et al. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Ibid. 1995; 8: 1506- 1513.
  7. van Noord J. A., Smeets J. J., Custers F. L. I. et al. Pharmacodynamic steady-state of tiotropium in patients with chronic obstructive pulmonary disease. Ibid. 2002; 19: 639-634.
  8. Casaburi R., Mahler D. A., Jones P. W. et al. A longterm evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Ibid. 217-224.
  9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 1995; 152: S77- S120.
  10. Mahler D. A., Weinberg D. H., Wells С. К., Feinstein A. R. The measurement of dyspnea: contents, interobserver agreement and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-758.
  11. Ware J. E., Sherbourne С D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med. Care 1992; 30: 472-483.
  12. Jones P. W., Quirk F. В., Baveystock С. М., Littlejohns P. A selfcomplete measure for chronic airflow limitation - the St George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321-1327.
  13. Vincken W., van Noord J. A., Greefhorst A. R. M. et al. Improved health outcomes in patients with COPD during I yr's treatment with tiotropium. Eur. Respir. J. 2002; 19: 209-216.
  14. Global initiative for chronic obstructive lung disease. Jeneva: WHO; 2002.
  15. Donahue J. F., van Noord J. A., Bateman E. D. et al. A 6month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.

Statistics

Views

Abstract: 133

Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2003 Shmelev E.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies